Two Percent of All Female Newborns in the United States Are at Risk of Getting Ovarian Cancer
As many as 30,000 U.S. women will be diagnosed with ovarian cancer this year. In 2006, between 15,000 and 16,000 women are likely to die from this silent killer. Ovarian cancer is the 5th leading cause of death among [...]
OvaRex® MAb is a monoclonal antibody – a biotech drug – designed to help the patient’s immune system recognize and more effectively fight ovarian cancer. OvaRex® MAb is given during the ‘watchful waiting’ period, following successful front-line therapy. It may become recognized as the most significant advance in ovarian cancer treatment since the use of [...]
At long last, some good news! A scientist found the cause of cancer, and it’s not what many scientists in the academia, at the National Institute of Health (NIH), or in pharmaceutical/biotech companies think.
